| Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study A Gafita, J Calais, TR Grogan, B Hadaschik, H Wang, M Weber, S Sandhu, ... The Lancet Oncology 22 (8), 1115-1125, 2021 | 139 | 2021 |
| qPSMA: semiautomatic software for whole-body tumor burden assessment in prostate cancer using 68Ga-PSMA11 PET/CT A Gafita, M Bieth, M Krönke, G Tetteh, F Navarro, H Wang, E Günther, ... Journal of Nuclear Medicine 60 (9), 1277-1283, 2019 | 96 | 2019 |
| Novel framework for treatment response evaluation using PSMA PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0): an international multicenter study A Gafita, I Rauscher, M Weber, B Hadaschik, H Wang, WR Armstrong, ... Journal of Nuclear Medicine 63 (11), 1651-1658, 2022 | 70 | 2022 |
| Tumor sink effect in 68Ga-PSMA-11 PET: myth or reality? A Gafita, H Wang, A Robertson, WR Armstrong, R Zaum, M Weber, ... Journal of Nuclear Medicine 63 (2), 226-232, 2022 | 48 | 2022 |
| The added value of PSMA PET/MR radiomics for prostate cancer staging EL Solari, A Gafita, S Schachoff, B Bogdanović, A Villagrán Asiares, ... European journal of nuclear medicine and molecular imaging 49 (2), 527-538, 2022 | 46 | 2022 |
| Efficacy and safety of 177Lu-labeled prostate-specific membrane antigen radionuclide treatment in patients with diffuse bone marrow involvement: a multicenter retrospective study A Gafita, WP Fendler, W Hui, S Sandhu, M Weber, R Esfandiari, J Calais, ... European Urology 78 (2), 148-154, 2020 | 46 | 2020 |
| Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria A Gafita, I Rauscher, WP Fendler, V Murthy, W Hui, WR Armstrong, ... European Journal of Nuclear Medicine and Molecular Imaging 49 (12), 4271-4281, 2022 | 42 | 2022 |
| Regional lymph node metastasis on prostate specific membrane antigen positron emission tomography correlates with decreased biochemical recurrence-free and therapy-free … T Amiel, C Würnschimmel, M Heck, T Horn, N Nguyen, L Budäus, ... The Journal of Urology 205 (6), 1663-1670, 2021 | 28* | 2021 |
| Evaluation of SUV normalized by lean body mass (SUL) in 68Ga-PSMA11 PET/CT: a bi-centric analysis A Gafita, J Calais, C Franz, I Rauscher, H Wang, A Roberstson, J Czernin, ... EJNMMI research 9, 1-6, 2019 | 16 | 2019 |
| Utility of 18F-rhPSMA-7.3 positron emission tomography for imaging of primary prostate cancer and pre-operative efficacy in N-staging of unfavorable intermediate to very high … T Langbein, H Wang, I Rauscher, M Krönke, K Knorr, A Wurzer, ... Journal of Nuclear Medicine, 2022 | 13 | 2022 |
| PSMA-ligand uptake can serve as a novel biomarker in primary prostate cancer to predict outcome after radical prostatectomy H Wang, T Amiel, C Würnschimmel, T Langbein, K Steiger, I Rauscher, ... EJNMMI research 11 (1), 76, 2021 | 11 | 2021 |
| The influence of specific activity on the biodistribution of 18F-rhPSMA-7.3: a retrospective analysis of clinical PET data T Langbein, A Wurzer, A Gafita, A Robertson, H Wang, A Arçay, M Herz, ... Journal of Nuclear Medicine 63 (5), 742-745, 2022 | 9 | 2022 |
| EORTC risk tables are more suitable for Chinese patients with nonmuscle-invasive bladder cancer than AUA risk stratification H Wang, W Ding, G Jiang, Y Gou, C Sun, Z Chen, K Xu, G Xia Medicine 97 (36), e12006, 2018 | 8 | 2018 |
| Exceptional 4-year response to 177Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer A Gafita, H Wang, R Tauber, C D’Alessandria, WA Weber, M Eiber European Journal of Nuclear Medicine and Molecular Imaging 46, 2212-2213, 2019 | 6 | 2019 |
| Mimics 三维重建模型在人体解剖学学习中的应用 王卉， 吴涛 中国医学教育技术 26 (6), 664-667, 2012 | 6 | 2012 |
| 甲状腺微创手术入路的进展及相关颈部层面解剖 王卉， 吴涛 中国临床解剖学杂志 31 (4), 491-494, 2013 | 4 | 2013 |
| Prognostic markers for overall survival and outcome to LuPSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer. A Gafita, J Calais, H Wang, M Weber, H Rathke, C Kratochwil, ... Journal of Clinical Oncology 38 (15_suppl), 5548-5548, 2020 | 3 | 2020 |
| Predictive factors and prediction nomograms for LuPSMA radioligand therapy in patients with metastatic castration-resistant prostate cancer: an international multicentre … A Gafita, J Calais, W Hui, M Weber, H Rathke, R Esfandiari, W Armstrong, ... Journal of Nuclear Medicine 61 (supplement 1), 593-593, 2020 | 3 | 2020 |
| DHS 与 PFNA 治疗粗隆间骨折疗效分析 王卉， 黄淑梅， 田京 生物骨科材料与临床研究 10 (4), 46-48, 2013 | 3 | 2013 |
| 腹腔镜胰腺外科的现状及展望 王卉 腹腔镜外科杂志 17 (10), 794-798, 2012 | 3 | 2012 |
